Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Conference News AHA 2020

Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF

Todd Neale

November 16, 2020

News Conference News TCT 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

Michael O'Riordan

October 17, 2020

Presentation TCT 2020

TCT 334: Beneficial Left Ventricular Remodeling and Hemodynamic Improvement Following Transcatheter Mitral Valve Replacement with an Apically-Tethered Prosthesis

Presenter: Paul Sorajja

October 14, 2020

News Daily News

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

Shelley Wood

September 18, 2020

News Conference News ESC 2020

Implantation Technique Influences LV Remodeling After TMVR

Todd Neale

September 04, 2020

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Conference News ACC 2020

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

Michael O'Riordan

March 28, 2020

News Opinion CV Team Dispatch

March 2020 News Roundup

L.A. McKeown

March 12, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Daily News

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

Michael O'Riordan

February 13, 2020

News Daily News

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Caitlin E. Cox

January 14, 2020

Advertisement

Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

TCT 334: Beneficial Left Ventricular Remodeling and Hemodynamic Improvement Following Transcatheter Mitral Valve Replacement with an Apically-Tethered Prosthesis

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

Implantation Technique Influences LV Remodeling After TMVR

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

March 2020 News Roundup

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content